Literature DB >> 26659684

Draft Genome Sequence of Streptomyces sp. TP-A0356, a Producer of Yatakemycin.

Hisayuki Komaki1, Natsuko Ichikawa2, Akira Hosoyama2, Nobuyuki Fujita2, Yasuhiro Igarashi3.   

Abstract

Here, we report the draft genome sequence of Streptomyces sp. TP-A0356, a producer of a potent antitumor antibiotic, yatakemycin, to evaluate potential for secondary metabolite production. The genome sequence data suggest the presence of at least nine gene clusters for polyketide synthases and nonribosomal peptide synthetases in this strain.
Copyright © 2015 Komaki et al.

Entities:  

Year:  2015        PMID: 26659684      PMCID: PMC4675949          DOI: 10.1128/genomeA.01446-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Yatakemycin is the most potent member of a class of DNA-alkylating agents that also includes CC-1065 and duocarmycins (1, 2). The complete sequence of the yatakemycin biosynthetic gene cluster and the biosynthetic pathway has been reported (3). As a part of our screening for novel secondary metabolites through a genome mining approach (4), the yatakemycin-producer Streptomyces sp. TP-A0356 was subjected to the whole-genome shotgun sequencing to survey polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) genes. Streptomyces sp. TP-A0356 was deposited to the NBRC culture collection (NBRC 110464). The genomic DNA of the strain TP-A0356 monoisolate was sequenced by a combined method of shotgun sequencing using 454 GS FLX Titanium (Roche) and paired-end sequencing with MiSeq (Illumina). A hybrid assembly of the 454 GS FLX Titanium data (73 Mb, 8.7-fold coverage) and the Illumina paired-end data (774 Mb, 92-fold coverage) was performed with Newbler version 2.8 (Roche). Contigs obtained from the assembly were subsequently finished using GenoFinisher (5). The resulting scaffolds were analyzed using Prodigal (6) for the prediction of protein-coding genes. The draft genome sequence of strain TP-A0356 consists of 62 scaffolds with a total size of 8,409,357 bp, 101-fold sequencing coverage, and 70.8% G+C content. PKS and NRPS gene clusters were searched for in the same manner as previously described (7). The genome contains at least five type I PKS gene clusters, one type II PKS gene cluster, and three NRPS gene clusters. Four type I PKS gene clusters were divided into scaffold-12 and -21, scaffold-14 and -47, scaffold-37, -48, and -55, and scaffold-56, -58, and -59. The PKSs in scaffold-12 and -21 show 74 to 94% sequence identities to polyunsaturated fatty acid synthases (PfaA and PfaC) of Streptomyces sp. SPB74. Two PKSs, orf1 and orf2 in scaffold-37, show about 60% sequence identity to SalB and SalA, respectively, for salinomycin synthesis (8). The type II PKS gene cluster in scaffold-3 is speculated to be involved in spore pigment production. The NRPS gene clusters have only a single module, indicating that their products are small peptides. Most of the PKS and NRPS gene clusters do not show high similarities to gene clusters of known compounds. These bioinformatic analytical data suggest the potential of strain TP-A0356 to produce unknown metabolites of type I PKS origin.

Nucleotide sequence accession numbers.

The draft genome sequence of Streptomyces sp. TP-A0356 has been deposited in the DDBJ/ENA/GenBank database under the accession no. BBZJ00000000. The version described in this paper is the first version, BBZJ01000000.
  8 in total

Review 1.  Genome mining for novel natural product discovery.

Authors:  Gregory L Challis
Journal:  J Med Chem       Date:  2008-04-05       Impact factor: 7.446

2.  Characterization of yatakemycin gene cluster revealing a radical S-adenosylmethionine dependent methyltransferase and highlighting spirocyclopropane biosynthesis.

Authors:  Wei Huang; Hui Xu; Yan Li; Feng Zhang; Xin-Ya Chen; Qing-Li He; Yasuhiro Igarashi; Gong-Li Tang
Journal:  J Am Chem Soc       Date:  2012-05-21       Impact factor: 15.419

3.  Yatakemycin, a novel antifungal antibiotic produced by Streptomyces sp. TP-A0356.

Authors:  Yasuhiro Igarashi; Katsuyuki Futamata; Tsuyoshi Fujita; Akira Sekine; Hisato Senda; Hideo Naoki; Tamotsu Furumai
Journal:  J Antibiot (Tokyo)       Date:  2003-02       Impact factor: 2.649

4.  Prodigal: prokaryotic gene recognition and translation initiation site identification.

Authors:  Doug Hyatt; Gwo-Liang Chen; Philip F Locascio; Miriam L Land; Frank W Larimer; Loren J Hauser
Journal:  BMC Bioinformatics       Date:  2010-03-08       Impact factor: 3.169

5.  Complete genome sequence of Acidovorax sp. strain KKS102, a polychlorinated-biphenyl degrader.

Authors:  Yoshiyuki Ohtsubo; Fumito Maruyama; Hisayuki Mitsui; Yuji Nagata; Masataka Tsuda
Journal:  J Bacteriol       Date:  2012-12       Impact factor: 3.490

6.  DNA alkylation properties of yatakemycin.

Authors:  Jay P Parrish; David B Kastrinsky; Scott E Wolkenberg; Yasuhiro Igarashi; Dale L Boger
Journal:  J Am Chem Soc       Date:  2003-09-10       Impact factor: 15.419

7.  Multiple regulatory genes in the salinomycin biosynthetic gene cluster of Streptomyces albus CCM 4719.

Authors:  R Knirschová; R Nováková; L Fecková; J Timko; J Turna; J Bistáková; J Kormanec
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

8.  Draft Genome Sequence of Marine-Derived Streptomyces sp. TP-A0873, a Producer of a Pyrrolizidine Alkaloid Bohemamine.

Authors:  Hisayuki Komaki; Natsuko Ichikawa; Akira Hosoyama; Nobuyuki Fujita; Yasuhiro Igarashi
Journal:  Genome Announc       Date:  2015-02-19
  8 in total
  1 in total

1.  Toxicity and repair of DNA adducts produced by the natural product yatakemycin.

Authors:  Elwood A Mullins; Rongxin Shi; Brandt F Eichman
Journal:  Nat Chem Biol       Date:  2017-07-24       Impact factor: 15.040

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.